At Infused Health, we specialize in delivering advanced infusion and injection therapies for patients with chronic gastrointestinal conditions such as Crohn’s disease and ulcerative colitis. We partner with gastroenterologists and primary care providers to ensure seamless, comfortable treatment experiences using FDA-approved biologics and biosimilars.

​

Current Therapies Offered​​

Biologics and Biosimilars for IBD and Related Conditions:

• AVSOLA®—Treats Crohn’s disease, ulcerative colitis, rheumatoid arthritis, plaque psoriasis, ankylosing spondylitis, and psoriatic arthritis.

• CIMZIA®—Approved for Crohn’s disease and also used for plaque psoriasis, psoriatic arthritis, and rheumatoid arthritis.

• ENTYVIO®—GI-specific biologic for ulcerative colitis and Crohn’s disease. Targets the gut selectively to reduce inflammation.

• INFLECTRA®—Biosimilar to Remicade; treats Crohn’s, ulcerative colitis, RA, psoriasis, and more.

• OMVOH™—For moderate to severe ulcerative colitis and Crohn’s disease.

• REMICADE®—Infliximab-based infusion for IBD and inflammatory arthritis.

• RENFLEXIS®—Another Remicade biosimilar with similar uses: Crohn’s, UC, RA, ankylosing spondylitis, and psoriasis.

• RITUXAN®—Used for RA, vasculitis, and certain GI-related autoimmune disorders. Also approved for NHL and CLL.

• RUXIENCE®—Biosimilar to Rituxan with the same indications, including RA and autoimmune vasculitis.

• SKYRIZI®—For Crohn’s disease, plaque psoriasis, and psoriatic arthritis.

• STELARA®—Treats Crohn’s, ulcerative colitis, plaque psoriasis, and psoriatic arthritis.

• TREMFYA®—For ulcerative colitis, plaque psoriasis, and psoriatic arthritis.

• TYSABRI®—Approved for Crohn’s and multiple sclerosis.

​​

​

Providers: Click on any medication name below to download the referral form.